For help on how to get the results you want, see our search tips.
98 results
-
List item
Orphan designation: Cladribine for: Treatment of indolent non-Hodgkin's lymphoma
Date of designation: 18/09/2001, Expired, Last updated: 18/06/2014 -
List item
Orphan designation: 1,5-(Butylimino)-1,5-dideoxy, D-glucitol for: Treatment of Gaucher disease
Date of designation: 18/10/2000, Expired, Last updated: 27/02/2013 -
List item
Orphan designation: Bosentan for: Treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Date of designation: 15/02/2001, Expired, Last updated: 27/02/2013 -
List item
Orphan designation: Anagrelide hydrochloride for: Treatment of essential thrombocythaemia
Date of designation: 30/12/2000, Expired, Last updated: 08/02/2017 -
List item
Orphan designation: Zinc acetate dihydrate for: Treatment of Wilson's disease
Date of designation: 31/07/2001, Expired, Last updated: 06/03/2015 -
List item
Orphan designation: Pirfenidone for: Treatment of idiopathic pulmonary fibrosis
Date of designation: 16/11/2004, Expired, Last updated: 22/03/2021 -
List item
Orphan designation: 4-(3,5-Bis(hydroxy-phenyl)-1,2,4) triazol-1-yl) benzoic acid for: Treatment of chronic iron overload requiring chelation therapy
Date of designation: 13/03/2002, Expired, Last updated: 30/09/2016 -
List item
Orphan designation: Dexrazoxane for: Treatment of anthracycline extravasations
Date of designation: 19/09/2001, Expired, Last updated: 30/09/2016 -
List item
Orphan designation: nitisinone for: Treatment of tyrosinaemia type 1
Date of designation: 30/12/2000, Expired, Last updated: 08/05/2015 -
List item
Orphan designation: Alpha-galactosidase A for: Treatment of Fabry disease
Date of designation: 08/08/2000, Expired, Last updated: 18/11/2011 -
List item
Orphan designation: imatinib mesilate for: Treatment of chronic myeloid leukaemia
Date of designation: 15/02/2001, Expired, Last updated: 10/02/2015 -
List item
Orphan designation: Recombinant human acid alpha-glucosidase for: Treatment of glycogen storage disease type II (Pompe's disease)
Date of designation: 15/02/2001, Expired, Last updated: 10/08/2016 -
List item
Orphan designation: imatinib mesilate for: Treatment of dermatofibrosarcoma protuberans
Date of designation: 26/08/2005, Expired, Last updated: 09/02/2015 -
List item
Orphan designation: Hydroxyurea for: Treatment of sickle cell syndrome
Date of designation: 09/07/2003, Expired, Last updated: 06/08/2017 -
List item
Orphan designation: Alpha-galactosidase A for: Treatment of Fabry disease
Date of designation: 08/08/2000, Expired, Last updated: 18/11/2011 -
List item
Orphan designation: Pegvisomant for: Treatment of acromegaly
Date of designation: 15/02/2001, Expired, Last updated: 27/02/2013 -
List item
Orphan designation: Sorafenib tosilate for: Treatment of hepatocellular carcinoma
Date of designation: 11/04/2006, Expired, Last updated: 31/01/2018 -
List item
Orphan designation: 2-Chloro-9-[2-deoxy-2-fluoro-ß-D-arabinofuranosyl]adenine for: Treatment of acute lymphoblastic leukaemia
Date of designation: 05/02/2002, Expired, Last updated: 10/08/2016 -
List item
Orphan designation: Caffeine citrate for: Treatment of primary apnoea of premature newborns
Date of designation: 18/02/2003, Expired, Last updated: 11/07/2019 -
List item
Orphan designation: stiripentol for: Treatment of severe myoclonic epilepsy in infancy
Date of designation: 06/12/2001, Expired, Last updated: 08/02/2017 -
List item
Orphan designation: trabectedin for: Treatment of ovarian cancer
Date of designation: 17/10/2003, Expired, Last updated: 27/11/2019 -
List item
Orphan designation: carglumic acid for: Treatment of propionic acidaemia
Date of designation: 07/11/2008, Expired, Last updated: 09/06/2021 -
List item
Orphan designation: icatibant acetate for: Treatment of angioedema
Date of designation: 18/02/2003, Expired, Last updated: 12/08/2020 -
List item
Orphan designation: carglumic acid for: Treatment of isovaleric acidaemia
Date of designation: 07/11/2008, Expired, Last updated: 09/06/2021 -
List item
Orphan designation: Eculizumab for: Treatment of paroxysmal nocturnal haemoglobinuria
Date of designation: 17/10/2003, Expired, Last updated: 20/11/2019